| Literature DB >> 33640685 |
Eun Jin Yoon1, Zahinoor Ismail2, Iris Kathol1, Mekale Kibreab1, Tracy Hammer1, Stefan Lang1, Mehrafarin Ramezani1, Noémie Auclair-Ouellet3, Justyna R Sarna1, Davide Martino1, Sarah Furtado1, Oury Monchi4.
Abstract
Mild behavioral impairment (MBI) is a neurobehavioral syndrome characterized by later life emergence of sustained neuropsychiatric symptoms, as an at-risk state for incident cognitive decline and dementia. Prior studies have reported that neuropsychiatric symptoms are associated with cognitive abilities in Parkinson's disease (PD) patients, and we have recently found a strong correlation between MBI and cognitive performance. However, the underlying neural activity patterns of cognitive performance linked to MBI in PD are unknown. Fifty-nine non-demented PD patients and 26 healthy controls were scanned using fMRI during performance of a modified version of the Wisconsin card sorting task. MBI was evaluated using the MBI-checklist, and PD patients were divided into two groups, PD-MBI and PD-noMBI. Compared to the PD-noMBI group and healthy controls, the PD-MBI group revealed less activation in the prefrontal and posterior parietal cortices, and reduced deactivation in the medial temporal region. These results suggest that in PD, MBI reflects deficits in the frontoparietal control network and the hippocampal memory system.Entities:
Keywords: Cognition; Mild behavioral impairment; Neuropsychiatric symptoms; Parkinson’s disease; Set-shifting; fMRI
Year: 2021 PMID: 33640685 PMCID: PMC7907973 DOI: 10.1016/j.nicl.2021.102590
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Demographic and clinical characteristics of participants.
| Characteristics | Healthy Control (n = 26) | PD-noMBI (n = 38) | PD-MBI (n = 21) | P-value | ||
|---|---|---|---|---|---|---|
| HC vs PD-noMBI | HC vs PD-MBI | PD-noMBI vs PD-MBI | ||||
| Age, mean ± SD (range), years | 68.6 ± 6.1 (60.1–80.9) | 69.9 ± 6.3 (58.5–80.1) | 70.9 ± 6.6 (57.9–81.3) | 0.816 | 0.533 | 0.826 |
| Female, No. (%) | 16 (62) | 15 (39) | 5 (24) | 0.204 | 0.037 | 0.263 |
| Education, mean ± SD (range), years | 16.4 ± 2.8 (12–21) | 15.4 ± 2.6 (9–21) | 14.1 ± 3.4 (9–20) | 0.180 | 0.024 | 0.176 |
| Disease duration, mean ± SD (range), years | na | 5.0 ± 3.5 (0.7–12.5) | 5.0 ± 2.7 (1.2–10.2) | na | na | 0.733 |
| LED, mean ± SD (range), mg/day | na | 681.1 ± 272.2 (225–1350) | 882.8 ± 478.0 (300–1925) | na | na | 0.198 |
| UPDRS-III, mean ± SD (range) | na | 15.3 ± 7.8 (4–34) | 21.9 ± 8.4 (6–40) | na | na | 0.003 |
| PD subtype, No. (%) | na | na | 0.055 | |||
| Tremor | 12 (32) | 1 (5) | ||||
| Mixed | 3 (8) | 3 (14) | ||||
| A/R | 23 (60) | 17 (81) | ||||
| MoCA, mean ± SD | 27.6 ± 1.8 (23–30) | 26.6 ± 2.4 (20–30) | 23.5 ± 4.4 (16–30) | 0.367 | <0.001 | <0.001 |
| MBI-C, mean ± SD (range) | ||||||
| Total | 0.0 ± 1.4 (0–7) | 1.6 ± 2.0 (0–7) | 15.1 ± 9.3 (8–44) | <0.001 | <0.001 | <0.001 |
| Drive/Motivation | 0.1 ± 0.4 (0–2) | 0.6 ± 0.9 (0–3) | 3.4 ± 2.9 (0–11) | 0.004 | <0.001 | <0.001 |
| Mood/Anxiety | 0.1 ± 0.4 (0–2) | 0.5 ± 1.0 (0–4) | 4.5 ± 2.3 (1–9) | 0.079 | <0.001 | <0.001 |
| Impulse dyscontrol | 0.2 ± 0.8 (0–4) | 0.4 ± 0.8 (0–4) | 5.0 ± 5.4 (0–21) | 0.072 | <0.001 | <0.001 |
| Social inappropriateness | 0.0 ± 0.0 | 0.1 ± 0.3 (0–1) | 1.5 ± 2.3 (1–10) | 0.134 | <0.001 | <0.001 |
| Abnormal perception/thought | 0.0 ± 0.0 | 0.2 ± 0.7 (0–4) | 0.7 ± 1.0 (0–3) | 0.082 | <0.001 | 0.006 |
HC, healthy controls; PD, Parkinson’s disease; MBI, Mild Behavioral Impairment; PD-noMBI, PD without MBI; PD-MBI, PD with MBI; LED, levodopa equivalent dose; UPDRS-III, motor section of the unified Parkinson’s disease rating scale; MoCA, Montreal cognitive assessment; A/R, akinetic/rigidity; MBI-C, MBI checklist; SD, standard deviation; na, not applicable.
One-way ANOVA with Tukey’s post hoc test.
Chi-square test with Bonferroni correction, p < 0.016 was considered significant (p = 0.05/3).
Kruskal-Wallis test followed by Mann-Whitney U test using Bonferroni correction, p < 0.016 was considered significant (p = 0.05/3).
Mann-Whitney U test.
Motor phenotypes were identified based on the ratio of mean tremor to the mean akinetic/rigid score of UPDRS-III. Patients with a ratio greater than 1.0, <0.80, and between 0.80 and 1.0 were classified into tremor, akinetic/rigid, and mixed types respectively (Schiess et al., 2000). The group difference was evaluated using Chi-square test.
Fig. 1Brain regions with significant activation in the contrast receiving negative feedback (RNF) vs. receiving positive feedback (RPF), corresponding to planning the set-shift. A) healthy controls (HC), B) Parkinson’s disease patients (PD) without mild behavioral impairment (MBI, PD-noMBI), and C) PD with MBI (PD-MBI). Red-to-yellow color means more activation in the RNF than RPF, and blue-to-light blue color means less activation in the RNF than RPF. D) Brain regions showing significant reduced activity in the PD-MBI group compared with HC and E) compared with PD-noMBI. F) The comparison between the PD-noMBI and PD-MBI groups after controlling for Montreal cognitive assessment (MoCA). The number under each slice is a z-coordinate. Rh, right hemisphere; Lh, left hemisphere. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 2Brain regions showing significant main effect of A) mild behavioral impairment (MBI) and B) mild cognitive impairment (MCI) in 2-way analysis of covariance. The number under each slice is a z-coordinate. Rh, right hemisphere; Lh, left hemisphere.
Fig. 3Brain regions with significant activation in the contrast matching after negative feedback (MNF) vs. matching after positive feedback (MPF), corresponding to executing the set-shift. A) healthy controls (HC) and B) Parkinson’s disease patients (PD) without mild behavioral impairment (MBI, PD-noMBI). For the PD with MBI (PD-MBI) group, there was no significant activation. Red-to-yellow color means more activation in the MNF than MPF. C) Brain regions showing significant reduced activity in the PD-MBI group compared with HC. D) Brain regions showing significant correlation with MBI-C total score during executing the set-shift after controlling for Montreal cognitive assessment (MoCA). The number under each slice is z-coordinate for the axial slice and x-coordinate for the sagittal slice. Rh, right hemisphere; Lh, left hemisphere. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 4Results of ROI analysis. A) Group differences in percent signal changes in each ROI, B) correlations between MBI-C total scores and the hippocampal activity during planning the set-shift in all Parkinson’s disease (PD) patients. HC, healthy controls; PD-noMBI, PD without mild behavioral impairment (MBI); PD-MBI, PD with MBI; VLPFC, ventrolateral prefrontal cortex; PMC premotor cortex; HPC, hippocampus; Plan, planning a set-shift; Exe, executing a set-shift; MBI-C, MBI checklist.